These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

196 related items for PubMed ID: 10766179

  • 1. Lysis of MYCN-amplified neuroblastoma cells by MYCN peptide-specific cytotoxic T lymphocytes.
    Sarkar AK, Nuchtern JG.
    Cancer Res; 2000 Apr 01; 60(7):1908-13. PubMed ID: 10766179
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Expression of CD56 by human papillomavirus E7-specific CD8+ cytotoxic T lymphocytes correlates with increased intracellular perforin expression and enhanced cytotoxicity against HLA-A2-matched cervical tumor cells.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Roman JJ, Jayaprabhu S, Pecorelli S, Parham GP, Cannon MJ.
    Clin Cancer Res; 2001 Mar 01; 7(3 Suppl):804s-810s. PubMed ID: 11300476
    [Abstract] [Full Text] [Related]

  • 4. Induction of human tumor-associated differentially expressed gene-12 (TADG-12/TMPRSS3)-specific cytotoxic T lymphocytes in human lymphocyte antigen-A2.1-positive healthy donors and patients with advanced ovarian cancer.
    Bellone S, Anfossi S, O'Brien TJ, Cannon MJ, Silasi DA, Azodi M, Schwartz PE, Rutherford TJ, Pecorelli S, Santin AD.
    Cancer; 2009 Feb 15; 115(4):800-11. PubMed ID: 19117353
    [Abstract] [Full Text] [Related]

  • 5. Ran, a small GTPase gene, encodes cytotoxic T lymphocyte (CTL) epitopes capable of inducing HLA-A33-restricted and tumor-reactive CTLs in cancer patients.
    Azuma K, Sasada T, Takedatsu H, Shomura H, Koga M, Maeda Y, Yao A, Hirai T, Takabayashi A, Shichijo S, Itoh K.
    Clin Cancer Res; 2004 Oct 01; 10(19):6695-702. PubMed ID: 15475460
    [Abstract] [Full Text] [Related]

  • 6. CD44H expression by human neuroblastoma cells: relation to MYCN amplification and lineage differentiation.
    Gross N, Beretta C, Peruisseau G, Jackson D, Simmons D, Beck D.
    Cancer Res; 1994 Aug 01; 54(15):4238-42. PubMed ID: 7518353
    [Abstract] [Full Text] [Related]

  • 7. In vitro effects of MYCN sense and antisense expression in MYCN-amplified human neuroblastoma cells.
    Kavallaris M, Gardaneh M, Cheung B, Camacho ML, Hocker JE, Norris MD, Haber M, Marshall GM.
    Anticancer Res; 1998 Aug 01; 18(3A):1793-7. PubMed ID: 9673406
    [Abstract] [Full Text] [Related]

  • 8. Definition of an immunogenic region within the ovarian tumor antigen stratum corneum chymotryptic enzyme.
    Bondurant KL, Crew MD, Santin AD, O'Brien TJ, Cannon MJ.
    Clin Cancer Res; 2005 May 01; 11(9):3446-54. PubMed ID: 15867247
    [Abstract] [Full Text] [Related]

  • 9. A parathyroid-hormone-related-protein (PTH-rP)-specific cytotoxic T cell response induced by in vitro stimulation of tumour-infiltrating lymphocytes derived from prostate cancer metastases, with epitope peptide-loaded autologous dendritic cells and low-dose IL-2.
    Correale P, Micheli L, Vecchio MT, Sabatino M, Petrioli R, Pozzessere D, Marsili S, Giorgi G, Lozzi L, Neri P, Francini G.
    Br J Cancer; 2001 Nov 30; 85(11):1722-30. PubMed ID: 11742494
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Co-amplification of MYCN and a DEAD box gene (DDX1) in primary neuroblastoma.
    Squire JA, Thorner PS, Weitzman S, Maggi JD, Dirks P, Doyle J, Hale M, Godbout R.
    Oncogene; 1995 Apr 06; 10(7):1417-22. PubMed ID: 7731693
    [Abstract] [Full Text] [Related]

  • 12. [Immunotherapy for leukemia cells by using cytotoxic T lymphocyte specifically against WT1-derived peptide: an experimental study in vitro].
    Gu WY, Cao XS, Qiu GQ, Chen ZX, Sheng LX, Xie XB, He J, Cen JN, Shen HL.
    Zhonghua Yi Xue Za Zhi; 2005 Dec 28; 85(49):3475-80. PubMed ID: 16686063
    [Abstract] [Full Text] [Related]

  • 13. Human neuroblastoma cell lines are susceptible to lysis by natural killer cells but not by cytotoxic T lymphocytes.
    Main EK, Lampson LA, Hart MK, Kornbluth J, Wilson DB.
    J Immunol; 1985 Jul 28; 135(1):242-6. PubMed ID: 3158702
    [Abstract] [Full Text] [Related]

  • 14. Characterization of HLA-A3-restricted cytotoxic T lymphocytes reactive against the widely expressed tumor antigen telomerase.
    Vonderheide RH, Anderson KS, Hahn WC, Butler MO, Schultze JL, Nadler LM.
    Clin Cancer Res; 2001 Nov 28; 7(11):3343-8. PubMed ID: 11705846
    [Abstract] [Full Text] [Related]

  • 15. Minichromosome maintenance protein MCM7 is a direct target of the MYCN transcription factor in neuroblastoma.
    Shohet JM, Hicks MJ, Plon SE, Burlingame SM, Stuart S, Chen SY, Brenner MK, Nuchtern JG.
    Cancer Res; 2002 Feb 15; 62(4):1123-8. PubMed ID: 11861392
    [Abstract] [Full Text] [Related]

  • 16. Generation of cytotoxic T cell responses to an HLA-A24 restricted epitope peptide derived from wild-type p53.
    Umano Y, Tsunoda T, Tanaka H, Matsuda K, Yamaue H, Tanimura H.
    Br J Cancer; 2001 Apr 20; 84(8):1052-7. PubMed ID: 11308253
    [Abstract] [Full Text] [Related]

  • 17. In vitro induction of tumor-specific human lymphocyte antigen class I-restricted CD8 cytotoxic T lymphocytes by ovarian tumor antigen-pulsed autologous dendritic cells from patients with advanced ovarian cancer.
    Santin AD, Hermonat PL, Ravaggi A, Bellone S, Pecorelli S, Cannon MJ, Parham GP.
    Am J Obstet Gynecol; 2000 Sep 20; 183(3):601-9. PubMed ID: 10992180
    [Abstract] [Full Text] [Related]

  • 18. Superior antitumor in vitro responses of allogeneic matched sibling compared with autologous patient CD8+ T cells.
    Kausche S, Wehler T, Schnürer E, Lennerz V, Brenner W, Melchior S, Gröne M, Nonn M, Strand S, Meyer R, Ranieri E, Huber C, Falk CS, Herr W.
    Cancer Res; 2006 Dec 01; 66(23):11447-54. PubMed ID: 17145892
    [Abstract] [Full Text] [Related]

  • 19. Cell lineage and differentiation state are primary determinants of MYCN gene expression and malignant potential in human neuroblastoma cells.
    Spengler BA, Lazarova DL, Ross RA, Biedler JL.
    Oncol Res; 1997 Dec 01; 9(9):467-76. PubMed ID: 9495452
    [Abstract] [Full Text] [Related]

  • 20. Identification of antigenic epitopes recognized by Mac-2 binding protein-specific cytotoxic T lymphocytes for use in cancer immunotherapy.
    Ozaki Y, Kontani K, Teramoto K, Fujita T, Tezuka N, Sawai S, Watanabe H, Fujino S, Asai T, Ohkubo I.
    Biochem Biophys Res Commun; 2004 May 14; 317(4):1089-95. PubMed ID: 15094380
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.